You are here

alogliptin

Is 'No Worse Than Placebo' Good Enough For New Diabetes Drugs?

Forbes

Tue, 09/3/13 - 11:07 am

Bristol-Myers Squibb

Furiex Rises on FDA Approval of Takeda Diabetes Medicine

Bloomberg

Mon, 01/28/13 - 10:47 am

Furiex Pharmaceuticals

FDA announces approval of three new drugs to treat Type 2 diabetes

examiner.com

Sun, 01/27/13 - 11:35 am

type 2 diabetes

Furiex Pharmaceuticals

Takeda Diabetes Drug Succeeding Actos Wins FDA Approval

Bloomberg

Sun, 01/27/13 - 11:25 am

type 2 diabetes

Furiex Pharmaceuticals

Furiex Confirms Takeda's Resubmissions Of Alogliptin NDAs To FDA

NASDAQ

Sun, 07/29/12 - 01:03 pm

Furiex Pharmaceuticals

type 2 diabetes

FDA Delays Takeda's Replacement for Actos

Injury Board

Sat, 05/19/12 - 12:22 pm

Takeda submits new drug application in the U.S. for Type 2 Diabetes Continue reading on Examiner.com Takeda submits new drug application in the U.S. for Type 2 Diabetes

Wall Street Journal

Sat, 11/26/11 - 11:08 am

Takeda heads back to FDA with diabetes blockbuster hopeful

Fierce Biotech

Tue, 07/26/11 - 04:43 pm

Takeda to begin cardiovascular outcomes trial for alogliptin to treat type 2 diabetes

Pharmabiz

Sat, 08/29/09 - 11:24 am

Takeda Receives FDA Complete Response Letter for Alogliptin, an Investigational Treatment for Type 2 Diabetes

PR NewsWire

Sat, 06/27/09 - 02:33 pm

PPD shares fall on diabetes drug setback

Yahoo/AP

Thu, 06/4/09 - 12:41 pm

Schering Plough

Takeda to Delay New Diabetes Drug Filing in Europe

Bloomberg

Thu, 06/4/09 - 08:56 am

FDA Calendar Updates: Diabetes

Seeking Alpha

Thu, 04/23/09 - 09:49 am

Bristol-Myers Squibb

Takeda’s New Diabetes Drug Faces Eight-Month Delay

Bloomberg

Wed, 12/24/08 - 08:33 am